TAG:
biopsies
Scripps’ Tumor Board Finds Value in Digital Imaging of Slides
By Robert Michel | From the Volume XVI No. 14 – October 12, 2009 Issue
CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase afte…
August 31, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 12 – August 31, 2009 Issue
These days, you hear plenty about Web 2.0 and how it is revolutionizing the way people use the Internet. Pathologist Keith Kaplan, M.D., at the Mayo Clinic uses the term “Pathology 2.0” to describe how use of Web 2.0 technology will similarly transform the anatomic pathology prof…
ER/PR Testing in Canada Continues to Make News
By Robert Michel | From the Volume XVI No. 7 – May 18, 2009 Issue
CEO SUMMARY: In Canada, the story about inaccurate breast cancer testing just won’t go away. In March, the Cameron Report was made public with its assessment of lab testing failures in Newfoundland and Labrador. In April, the health system in those provinces admitted that it ne…
Why Wall Street Likes Histology Lab Business
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
CEO SUMMARY: Over the past two decades, investor-owned anatomic pathology companies captured significant market share from community hospital-based pathology groups while delivering profits to their owners. Despite the recent downturn in the economy, Wall Street believes histolog…
Toronto Pathologists Use Whole-Slide Imaging
By Robert Michel | From the Volume XV No. 9 – July 7, 2008 Issue
CEO SUMMARY: It was the “frozen section problem” and productivity issues that led pathologists at the three-hospital University Health Network (UHN) in Toronto to implement a fully-digital pathology system with whole-slide imaging in 2006. Use of digital, whole-slide …
Ruling Against UroPath Signals More Fed Action
By Robert Michel | From the Volume XV No. 7 – May 27, 2008 Issue
CEO SUMMARY: It was a signal win for federal healthcare officials when a federal district court judge in Washington, DC, dismissed a case brought by UroPath, LLC. UroPath had sued HHS Secretary Michael Leavitt seeking to challenge the physician fee schedule final order and the anti-markup…
Powerful Trends Reshaping Anatomic Path Profession
By Robert Michel | From the Volume XV No. 2 – February 11, 2008 Issue
CEO SUMMARY: THE DARK REPORT presents its newest biannual review of macro trends reshaping the anatomic pathology profession. These macro trends reveal a profession undergoing change and transformation on multiple fronts. New competitors are crowding into the market, payers and accreditin…
Anticipate Access/Service Decline for S.D. Patients
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: In its primary push to use the Medicare Laboratory Competitive Bidding Demonstration Project as a tool to drive down the price Medicare pays for Part B laboratory testing services, CMS is giving secondary attention to patients’ needs. In particular, CMS seems to place littl…
November 19, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 16 – November 19, 2007 Issue
Readers of THE DARK REPORT may want to check out the November issue of MLO Magazine. It profiles the experiences of four scholarship winners to the Executive War College last May in Miami, Florida. Winners were Pervez A. Mirza of State University of New York (SUNY) in Brooklyn, New Y…
Path Group Closes Its Lab After GIs Do In-Clinic Lab
By Robert Michel | From the Volume XIV No. 13 – September 17, 2007 Issue
CEO SUMMARY: Kettering Pathology Associates of Kettering, Ohio, built a thriving outreach pathology business in this Dayton suburb before three gastroenterology groups either sent biopsy work out of state or built their own lab, and asked the pathologists to provide contracted professiona…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized